175 related articles for article (PubMed ID: 3331321)
21. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
Kirby BJ; Kitchin NR
Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
[TBL] [Abstract][Full Text] [Related]
22. Persistence with antihypertensives related to formulation: the case of nifedipine.
Breekveldt-Postma NS; Herings RM
Ann Pharmacother; 2005 Feb; 39(2):237-42. PubMed ID: 15598968
[TBL] [Abstract][Full Text] [Related]
23. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
Croom KF; Wellington K
Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
25. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
[TBL] [Abstract][Full Text] [Related]
26. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
27. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension.
Houston MC; Hays L
Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450
[TBL] [Abstract][Full Text] [Related]
28. Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group.
Lubsen J; Poole-Wilson PA
Br J Clin Pract Suppl; 1997 Apr; 88():23-6. PubMed ID: 9519504
[TBL] [Abstract][Full Text] [Related]
29. Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study.
Zanolla L; Franceschini L; Rossi L; Ochan M; Amigoni S; Zardini P
Br J Clin Pract Suppl; 1997 Apr; 88():27-35. PubMed ID: 9519505
[TBL] [Abstract][Full Text] [Related]
30. Effects and mechanism of nifedipine after oral, sublingual, intravenous and intracoronary administration. Survey on clinical results.
Ebner F
Arq Bras Cardiol; 1984 Aug; 43(2):81-6. PubMed ID: 6152390
[No Abstract] [Full Text] [Related]
31. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
Lubsen J; Poole-Wilson PA; Pocock SJ; van Dalen FJ; Baumann J; Kirwan BA; Parker AB
Eur Heart J; 1998 Aug; 19 Suppl I():I20-32. PubMed ID: 9743440
[TBL] [Abstract][Full Text] [Related]
32. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
33. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
[TBL] [Abstract][Full Text] [Related]
34. Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Toal CB; Motro M; Baird MG; Klinke P; Sclarowski S; Zilberman A; Marmor A; Kostuk WJ; Lotan C; Weiss A; Erne P; Palant A; Stolero D; Bélanger L; Turpie A
Can J Cardiol; 1999 Oct; 15(10):1103-9. PubMed ID: 10523477
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
Toal CB
Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
[No Abstract] [Full Text] [Related]
38. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
Grzeszczak W
Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
[TBL] [Abstract][Full Text] [Related]
39. Nifedipine GITS (gastrointestinal therapeutic system) bezoar.
Prisant LM; Carr AA; Bottini PB; Kaesemeyer WH
Arch Intern Med; 1991 Sep; 151(9):1868-9. PubMed ID: 1888255
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and bioavailability of a sustained release nifedipine formulation.
Piovella C
Arzneimittelforschung; 1987 Jul; 37(7):832-5. PubMed ID: 3675679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
